Reasonable application of continuous subcutaneous insulin infusion in type 2 diabetic in-patients
- VernacularTitle:住院2型糖尿病患者胰岛素泵的合理应用
- Author:
Jianhua MA
;
Jindan WU
;
Xiaohua XU
;
Xiaojing XIE
;
Xiaofei SU
;
Hao LIU
;
Guoping YIN
;
Yun SHEN
;
Xiaoming MAO
;
Shaokang QI
- Publication Type:Journal Article
- Keywords:
Continuous subcutaneous insulin infusion;
Diabetes mellitus;
type 2;
Hospitalization
- From:
Chinese Journal of Endocrinology and Metabolism
2008;24(2):129-132
- CountryChina
- Language:Chinese
-
Abstract:
Objective To study the regiments of continuous subcutaneous insulin infusion (CSII) in admitted type 2 diabetic patients, and to analyse the factors related to its effectiveness and insulin dosage. Methods A total of 1 276 type 2 diabetic patients were treated by CSII. The total efficacy of CSII was evaluted. The use of CSII was also analysed in the newly diagnosed patients, elderly patients, and patients with obese or infectious disease. Results The excellent control of blood glucose were achieved in (5.7±2.6)days in the dosage more early and quickly in the newly diagnosed group than that in the previously diagnosed group after the blood glucose levels achieved good control. The percentage of the patients reached the clinical relieve was also higher in the newly diagnosed group. The incidence of hypoglycemia was significantly higher in the elderly patients with lower basal insulin dosage at night. The bolus insulin dosage in the obese patients was higher than that in the non-obese patients. The patients with infectious disease usually have a higher basal insulin dosage than those without infectious disease. The days needed for achieving good control of blood glucose and the insulin dosage were related to infectious factors, the basal blood glucose and obesity. Conclusion The application of CSII among the patients is varied with different conditions. Blood glucose level, body mass index and infection factors are important to determine the initial insulin dosage.
